BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 3, 2014
View Archived Issues
Researchers confirm ambidextrous chaperone activity of GroEL/ES
Read More
Alirocumab lowers the rate of major CV events in patients with hypercholesterolemia
Read More
4D pharma profiles pipeline progress
Read More
Jakavi launched in Japan
Read More
APD-811 granted FDA orphan drug status for pulmonary arterial hypertension
Read More
FDA grants fast track designation to motolimod for ovarian cancer
Read More
Xention and Servier begin first phase II study of XEN-D0103
Read More
Ozurdex approved in the E.U. for the treatment of diabetic macular edema
Read More
HanAll BioPharma discloses new AMPK activators
Read More
Zytiga launched in Japan for prostate cancer
Read More
FDA accepts NDA filing for eluxadoline, grants priority review
Read More
Novel NS5B inhibitors disclosed by Bristol-Myers Squibb
Read More
Amgen submits MAAs for talimogene laherparepvec and evolocumab in the E.U.
Read More
Merck & Co. synthesizes novel IRAK inhibitors
Read More
Reslizumab reduces asthma exacerbations in two pivotal phase III trials
Read More
Mitsubishi Tanabe Pharma and Daiichi Sankyo launch Canaglu in Japan
Read More
Draconis Pharma patents new EP4 receptor antagonists
Read More
Opdivo launched in Japan for unresectable melanoma
Read More
Nuplazid receives FDA breakthrough therapy designation for Parkinson's disease psychosis
Read More
Hua Medicine patents new mGlu5 receptor antagonists
Read More
Lundbeck launches Northera in U.S. for symptomatic neurogenic orthostatic hypotension
Read More
Final results of PARADIGM-HF and other studies presented for LCZ-696
Read More
Kaken launches Clenafin in Japan for tinea unguium
Read More
European orphan drug designations for CER-001 in apoA-I and ABCA1 deficiencies
Read More
Methotrexate receives FDA orphan drug status for myasthenia gravis
Read More
Phase II results for EPI-743 in Rett syndrome
Read More